Eltrombopag Treatment in Patients With Prolonged BM Toxicity After CART
Clinical trial NCT05286164 · UNKNOWN
Trial details
- NCT number
- NCT05286164
- Sponsor
- Tel-Aviv Sourasky Medical Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-01
- Primary completion
- 2023-04-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.